Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

ENZ
Enzo Biochem, Inc.
stock NYSE

Inactive
Apr 17, 2025
0.3138USD-17.767%(-0.0678)4,123,861
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-0.38)0
After-hours
Dec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 21, 2022
04:19PM EST  Enzo Biochem 8-K Shows Co. Co-Founder, Chair, Chief Scientific Officer Elazar Rabbani Was Terminated   Benzinga
Jan 3, 2022
04:10PM EST  Hamid Erfanian and Bradley Radoff Appointed to Enzo   GlobeNewswire Inc
Dec 16, 2021
08:20AM EST  The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street   Benzinga
Dec 15, 2021
04:08PM EST  Enzo Biochem Q1 EPS $(0.05) Down From $0.01 YoY, Sales $26.50M Down From $28.66M YoY   Benzinga
04:05PM EST  -- 1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing a 7% sequential increase -- Company appoints Hamid Erfanian as Chief Executive Officer -- Consolidated manufacturing footprint at state-of-the-art Farmingdale, NY campus to enhance operational efficiencies   GlobeNewswire Inc
08:03AM EST  The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO   Benzinga
03:50AM EST  Earnings Scheduled For December 15, 2021   Benzinga
Dec 2, 2021
04:05PM EST  Conference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET   GlobeNewswire Inc
Nov 9, 2021
10:18AM EST  ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER   GlobeNewswire Inc
Oct 25, 2021
08:14AM EDT  Bradley L. Radoff Issues Letter To Independent Directors Of Enzo Biochem   Benzinga
08:00AM EDT  Bradley L. Radoff Issues Letter to the Independent Directors of Enzo Biochem Regarding Their Unwillingness to Acknowledge or Address Unprecedented Shareholder Unrest   Business Wire
Oct 21, 2021
12:12PM EDT  Enzo Biochem Expands GoTestMe Now Online Portal To Provide Patients With Direct Access To Private Testing For Sexually Transmitted Infections   Benzinga
08:39AM EDT  -- GoTestMeNow enables individuals to instantly and privately access physician-authorized testing for a broad range of STIs including chlamydia, gonorrhea, syphilis, HIV-1/2, hepatitis and herpes -- Expanded menu addresses increased patient demand for direct access to other convenient diagnostic tests   GlobeNewswire Inc
Oct 19, 2021
07:12AM EDT  Urges Enzo Biochem To Pursue Negotiated Resolution With Shareholders, Not Force Unnecessary Election Contest   RTTNews
07:02AM EDT  Bradley L. Radoff Issues Open Letter to Recently-Appointed Independent Directors of Enzo Biochem   Business Wire
Oct 18, 2021
08:17AM EDT  Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer   GlobeNewswire Inc
Oct 12, 2021
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
07:14AM EDT  Enzo Biochem Q4 Adj. EPS $0.07 Up From $(0.07) YoY, Sales $24.81M Up From $19.53M YoY   Benzinga
07:00AM EDT  Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial   GlobeNewswire Inc
04:01AM EDT  Earnings Scheduled For October 12, 2021   Benzinga
Oct 10, 2021
11:59AM EDT  The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations and IPOs Take Center Stage   Benzinga
Oct 3, 2021
02:21PM EDT  The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs and More   Benzinga
Oct 1, 2021
12:45PM EDT  UPDATE: Enzo Biochem 13D Filing Shows James Wolf 'may nominate himself for election as a director of the Company at the next annual meeting of shareholders if he is not nominated by the Board of Directors'   Benzinga
12:41PM EDT  Enzo Biochem 13D Filing From James Wolf Shows New 5.4% Active Stake   Benzinga
Sep 28, 2021
08:00AM EDT  Conference Call and Webcast Scheduled for October 12, 2021, 8:30 am ET   GlobeNewswire Inc
Sep 2, 2021
04:05PM EDT  Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually from September 13th - 15th.   GlobeNewswire Inc
Jul 20, 2021
09:01AM EDT  FDA Expands EUA For Rapid Extraction On One COVID-19 Test System   Benzinga
08:29AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jul. 20, 2021: NFLX, SFTW, AEHR, LCAP, ENZ   Benzinga
08:01AM EDT  Enzo Biochem Reports FDA Emergency Use Authorization For Rapid Extraction Method On Proprietary Test System For Detection Of Coronavirus SARS-CoV-2   Benzinga
08:00AM EDT  ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID   GlobeNewswire Inc
Jun 15, 2021
12:00PM EDT  Testing will be available through CLX Healths TrustAssure Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to travel.   GlobeNewswire Inc
Jun 14, 2021
04:15PM EDT  Enzo Biochem On June 14, Received Notification That Sba Rendered Final Decision Regarding Its Review Of Co.'s PPP Loan Forgiveness Application   Benzinga
Jun 9, 2021
04:08PM EDT  Enzo Biochem Q3 EPS $0.04 Up From $(0.17) YoY, Sales $32.80M Up From $16.90M YoY   Benzinga
04:05PM EDT  Enzo Biochem Reports Third Quarter Fiscal 2021 Results   GlobeNewswire Inc
04:04AM EDT  Earnings Scheduled For June 9, 2021   Benzinga
Jun 1, 2021
04:05PM EDT  Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2021 financial results on Wednesday, June 9, 2021, after the market close. The announcement will be followed by a live audio webcast and conference call at 4:30 pm Eastern Time.   GlobeNewswire Inc
Apr 21, 2021
08:03AM EDT  Enzo Biochem Announces FDA Has Cleared Its AMPICOLLECT Sample Collection Kit   Benzinga
08:00AM EDT  Companys specimen collection kit now available for use in COVID-19 testing in the U.S.   GlobeNewswire Inc
Mar 22, 2021
09:31AM EDT  180 Degree Capital Sends Letter To Board, Shareholders Of Enzo Biochem   Benzinga
Mar 17, 2021
04:15PM EDT  Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum, Tuesday March 23rd at 10:45am ET. The format will be a "fireside chat" discussion hosted by KeyBancs Research Analyst Paul Knight.   GlobeNewswire Inc
Mar 16, 2021
03:32PM EDT  Harbert Discovery Fund Responds To Enzo Biochem, Inc.'s Recent Strategic Announcements; Says Believes Interested Acquirers, Others Would Be Willing To Pay Significant Premium To Enzo Biochem's Current Share Price, Outright Sale May Provide Highest Return   Benzinga
10:44AM EDT  Shares of biosciences and diagnostics company Enzo Biochem, Inc. (ENZ) are surging more than 45% Tuesday morning following second-quarter results.   RTTNews
08:37AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Mar. 16, 2021: ENZ, OCG, NHIC, HEXO, TKAT   Benzinga
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
07:16AM EDT  Enzo Therapeutics Awarded U.S. Patent 10,945,971 'Sphingosine kinase type 1 inhibitors and uses thereof'   Benzinga
Mar 15, 2021
04:06PM EDT  Enzo Biochem Q2 EPS $0.05 Up From $(0.12) YoY, Sales $31.50M Up From $19.38M YoY   Benzinga
04:05PM EDT  Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company   GlobeNewswire Inc
04:53AM EDT  Earnings Scheduled For March 15, 2021   Benzinga
Mar 14, 2021
08:14AM EDT  Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations   Benzinga
Mar 4, 2021
08:00AM EST  Enzo Biochem, Inc. (NYSE:ENZ) (Enzo or the Company), a leading biosciences and diagnostics company, today announced that the Company will present at H.C. Wainwright Global Life Sciences Conference, which is being held virtually from March 9-10, 2021.   GlobeNewswire Inc
Mar 2, 2021
08:10AM EST  Enzo Biochem Highlights Results Of An Analysis Showing Tests Processed On Its GENFLEX Platform Are Able To Detect Presence Of Currently Known COVID-19 Variants   Benzinga
08:00AM EST  Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations on testing results   GlobeNewswire Inc
Mar 1, 2021
04:05PM EST  Enzo Biochem, Inc. (NYSE:ENZ) (Enzo or the Company), a leading biosciences and diagnostics company, announced today that it will report second quarter 2021 financial results on Monday, March 15, 2021, after the market close. The announcement will be followed by a live audio webcast and conference call at 4:30 pm Eastern Time.   GlobeNewswire Inc
Feb 3, 2021
08:33AM EST  Enzo Announces Issuance Of U.S. Patent For 'Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin'   Benzinga
08:30AM EST  Enzo Biochem, Inc. (NYSE:ENZ) (Enzo or the Company), a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,899,827 entitled Antibodies Specific for Sulfation Sites of Sclerostin.   GlobeNewswire Inc
Jan 26, 2021
02:08PM EST  Enzo Biochem Awarded U.S. Patent # 10,899,827 'Antibodies specific for sulfation sites of sclerostin'   Benzinga
Jan 20, 2021
08:15AM EST  Enzo Biochem's Board Of Directors Forms New Corporate Development And Planning & Succession Committees   Benzinga
08:14AM EST  ENZO BIOCHEMS BOARD OF DIRECTORS FORMS NEW   GlobeNewswire Inc
Jan 5, 2021
01:34PM EST  Roumell Asset Management Reports From Annual Meeting Of Enzo Biochem Dr. Rabbani Received ~44% Of Shares Voting For His Re-Election   Benzinga
01:28PM EST  Roumell Announces Preliminary Annual Meeting Results for Enzo Biochem, Inc.   PR Newswire
08:00AM EST  Enzo Biochem, Inc. (NYSE:ENZ) (Enzo or The Company), a leading biosciences and diagnostics company, today announced that it will participate in the 10thAnnual LifeSci Partners Corporate Access Event,January 6-8and 11-14, 2021 in concurrence with J.P. Morgans 39th Annual Healthcare Conference.   GlobeNewswire Inc
Jan 4, 2021
07:40AM EST  Enzo Biochem, Inc. (ENZ) has received an expansion of its Emergency Use Authorization from the FDA authorizing the use of pooled samples containing up to five individual swab specimens with the AMPIPROBE SARS-Cov-2 Test System utilizing tests on three different platforms including Enzo's GENFLEX automated high-throughput platform.   RTTNews
07:13AM EST  Enzo Biochem Gets Expansion Of EUA From FDA Authorizing Use Of Pooled Samples On 3 Platforms Incl Proprietary GENFLEX   RTTNews
07:02AM EST  Enzo Biochem Receives FDA Emergency Use Authorization For Testing Pooled Samples On Three Platforms Including Company's Genflex Proprietary System For Detection Of Coronavirus Sars-CoV-2   Benzinga
07:00AM EST  - Use of pooled sampling with Enzos molecular diagnostic technology can help rapidly expand the number of people tested for COVID-19 -   GlobeNewswire Inc
Dec 31, 2020
01:47PM EST  Lewis, Recommend That Shareholders Vote AGAINST Elazar Rabbani at Enzo's Upcoming Annual Meeting   PR Newswire
Dec 29, 2020
06:24AM EST  Enzo Biochem 13D Shows 5.8% Stake From Roumell Asset Management, LLC; Roumell Criticizes Common Stock Bonuses   Benzinga
Dec 28, 2020
08:40AM EST  Enzo Biochem Says CEO And President Agree To Hold Common Stock Paid As Bonus   RTTNews
08:05AM EST  Enzo Biochem Issues Response Related To ISS View Of Compensation For Chair, CEO   Benzinga
08:00AM EST  ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL   GlobeNewswire Inc
Dec 24, 2020
02:07PM EST  Roumell Asset Management Files Definitive Proxy Statement and Sends Letter to   PR Newswire
Dec 15, 2020
08:00AM EST  Enzo Biochem Hosting Key Opinion Leader Call on   GlobeNewswire Inc
Dec 10, 2020
02:35AM EST  Earnings Scheduled For December 9, 2020   Benzinga
Dec 9, 2020
04:02PM EST  Enzo Biochem Q1 EPS $0.01 Up From $(0.13) YoY, Sales $28.70M Up From $20.21M YoY   Benzinga
04:01PM EST  Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results   GlobeNewswire Inc
04:18AM EST  Earnings Scheduled For December 9, 2020   Benzinga
Dec 6, 2020
08:41AM EST  Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace   Benzinga
Dec 2, 2020
08:00AM EST  Conference Call and Webcast Scheduled for December 9, 2020, 4:30 pm ET   GlobeNewswire Inc
Nov 25, 2020
08:00AM EST  Enzo Biochem, Inc. (NYSE:ENZ) (Enzo or The Company), a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Companys Board of Directors effective immediately.   GlobeNewswire Inc
Nov 18, 2020
03:40PM EST  Enzo Biochem 13D Filing From Harbert Fund Advisors Shows Unchanged 11.74% Stake; Includes 'Purpose Of Transaction' Fund 'sent a letter to the Board of the Issuer calling for the immediate resignation of Elazar Rabbani, the Chairman of the Board and CEO'   Benzinga
01:00PM EST  Harbert Discovery Fund Issues Letter to Enzo Biochem Board of   GlobeNewswire Inc
08:05AM EST  Enzo Biochem, Inc. (NYSE:ENZ) (Enzo or the Company), a leading biosciences and diagnostics company, announced today that Mary Tagliaferri, MD, has been appointed to the companys Board of Directors effective immediately.   GlobeNewswire Inc
Nov 17, 2020
10:10AM EST  Enzo Biochem shares were trading higher after the company announced that its Q1 sales meeting will exceed $27 million up from last year.   Benzinga
08:18AM EST  Enzo Biochem Expects Revenue To Meet Or Exceed $27M For Quarter Ended Oct. 31   Benzinga
08:02AM EST  Enzo Biochem Sees Q1 Sales Meeting Or Exceeding $27M, Up At Least 40% Quarter Over Quarter   Benzinga
08:00AM EST  Enzo Biochem, Inc. (NYSE:ENZ) (Enzo or The Company), a leading biosciences and diagnostics company, announced today that the company estimates revenue to meet or exceed $27 million, representing sequential growth of at least 40%, for the quarter ended October 31, 2020.   GlobeNewswire Inc
Nov 5, 2020
08:14AM EST  Enzo Biochem Launches Microplate Reader For Use With Its Elisa And Assay Kits   Benzinga
08:00AM EST  - Powerful and precise compact instrument enables Enzo to offer a complete solution to advance drug discovery   GlobeNewswire Inc
Oct 27, 2020
08:01AM EDT  Enzo Biochem Launches GoTestMeNow Online Platform For Consumers To Directly Order Coronavirus Laboratory Tests   Benzinga
08:01AM EDT  Direct-to-Consumer service will initially offer access to COVID-19 molecular and antibody testing and will expand to include other testing in the future   GlobeNewswire Inc
Oct 15, 2020
04:30PM EDT  Enzo Biochem Q4 EPS $(0.07) Up From $(0.11) YoY, Sales $19.50M   Benzinga
04:30PM EDT  CORRECTION From Oct. 13 Headline: Enzo Q4 Sales $19.5M; No Sell-Side Estimates Were Given   Benzinga
Oct 14, 2020
02:33PM EDT  Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Allscripts Healthcare Solutions Shares Jump   Benzinga
12:13PM EDT  Mid-Day Market Update: Crude Oil Rises 1.5%; Cyclerion Therapeutics Shares Plummet   Benzinga
10:14AM EDT  Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Tops Q3 Expectations   Benzinga
Oct 13, 2020
05:21PM EDT  10 Stocks Moving In Tuesday's After-Hours Session   Benzinga
04:05PM EDT  Enzo Biochem Q4 Loss/share $0.07 Vs. Loss $0.11 Year Ago   RTTNews
04:03PM EDT  Enzo Biochem Q4 EPS $(0.07) Up From $(0.11) YoY, Sales $19.50M Miss $20.92M Estimate   Benzinga
04:01PM EDT  -- Company reports $19.5 million in revenue and EPS of ($0.07) in the fourth quarter with significant margin expansion supported by rapid response to COVID-19 market opportunities -- Q1 21 first two months revenue reflect continued positive trend   GlobeNewswire Inc
04:07AM EDT  Earnings Scheduled For October 13, 2020   Benzinga
Oct 6, 2020
03:43PM EDT  Conference Call and Webcast Scheduled for October 13, 2020, 4:30 pm ET   GlobeNewswire Inc
Sep 8, 2020
08:20AM EDT  Enzo Biochem Doubles Capacity In Response To Increasing Demand For COVID-19 Testing   Benzinga
08:01AM EDT  Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it has expanded reagent and supply manufacturing as well as doubled its capacity for molecular laboratory testing services at its facilities in Farmingdale, NY to meet rapidly increasing demand for its PCR-based COVID-19 molecular and serological testing.   GlobeNewswire Inc
Jul 21, 2020
08:32AM EDT  Enzo Biochem To Provide Access To Coronavirus Testing At More Than 50 New York Pharmacies In Collaboration With CEPESN New York   Benzinga
08:30AM EDT  ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50   GlobeNewswire Inc
Jul 13, 2020
08:37AM EDT  Enzo Biochem Formally Receives EUA For Proprietary Test System For Detection Of Coronavirus   RTTNews
08:30AM EDT  Enzo Biochem Receives Emergency Use Authorization For Proprietary Test System For Detection Of Coronavirus SARS-CoV-2   Benzinga
08:30AM EDT  Flexible Use on Three Platforms including Enzos Proprietary Automated GENFLEX Platform   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC